ATE409179T1 - Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten - Google Patents
Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonistenInfo
- Publication number
- ATE409179T1 ATE409179T1 AT05825521T AT05825521T ATE409179T1 AT E409179 T1 ATE409179 T1 AT E409179T1 AT 05825521 T AT05825521 T AT 05825521T AT 05825521 T AT05825521 T AT 05825521T AT E409179 T1 ATE409179 T1 AT E409179T1
- Authority
- AT
- Austria
- Prior art keywords
- indande
- tetralin
- antagonists
- derivatives
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/12—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63803104P | 2004-12-21 | 2004-12-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE409179T1 true ATE409179T1 (de) | 2008-10-15 |
Family
ID=36143294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05825521T ATE409179T1 (de) | 2004-12-21 | 2005-12-12 | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten |
Country Status (15)
Country | Link |
---|---|
US (1) | US7576103B2 (de) |
EP (1) | EP1831152B1 (de) |
JP (1) | JP2008524277A (de) |
KR (1) | KR100889185B1 (de) |
CN (1) | CN101111472A (de) |
AT (1) | ATE409179T1 (de) |
AU (1) | AU2005318598B2 (de) |
BR (1) | BRPI0519709A2 (de) |
CA (1) | CA2591800A1 (de) |
DE (1) | DE602005009977D1 (de) |
ES (1) | ES2314749T3 (de) |
MX (1) | MX2007007482A (de) |
PL (1) | PL1831152T3 (de) |
RU (1) | RU2388748C2 (de) |
WO (1) | WO2006066748A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5394487B2 (ja) * | 2008-07-15 | 2014-01-22 | エフ.ホフマン−ラ ロシュ アーゲー | アミノテトラヒドロインダゾロ酢酸 |
WO2010006944A1 (en) | 2008-07-15 | 2010-01-21 | F. Hoffmann-La Roche Ag | Aminotetrahydroindazoloacetic acids |
WO2010018109A2 (en) * | 2008-08-15 | 2010-02-18 | F. Hoffmann-La Roche Ag | Substituted aminotetralines |
CA2732210A1 (en) * | 2008-08-15 | 2010-02-18 | F. Hoffmann-La Roche Ag | Monoaryl aminotetralines |
JP2012500189A (ja) * | 2008-08-15 | 2012-01-05 | エフ.ホフマン−ラ ロシュ アーゲー | ビアリールアミノテトラリン |
CA2740864A1 (en) * | 2008-11-17 | 2010-05-20 | F. Hoffmann-La Roche Ag | Naphthylacetic acids |
PL2346819T3 (pl) * | 2008-11-17 | 2013-09-30 | Hoffmann La Roche | Kwasy naftylooctowe |
EP2358677B1 (de) * | 2008-11-17 | 2014-01-08 | F. Hoffmann-La Roche AG | Als crth2-antagonisten oder partielle crth2-agonisten verwendete naphthylessigsäuren |
US8470884B2 (en) | 2011-11-09 | 2013-06-25 | Hoffmann-La Roche Inc. | Alkenyl naphthylacetic acids |
US9000044B2 (en) | 2012-02-28 | 2015-04-07 | Hoffmann-La Roche Inc. | Substituted naphthylacetic acids |
CN103998422B (zh) * | 2013-09-02 | 2016-11-30 | 北京英力科技发展有限公司 | 环戊二酮肟酯及其应用 |
WO2016082304A1 (zh) * | 2014-11-28 | 2016-06-02 | 北京英力科技发展有限公司 | 一种光固化阻焊油墨 |
CN110240537B (zh) * | 2019-05-22 | 2022-06-21 | 成都阿奇生物医药科技有限公司 | 一种茚氧乙酸类化合物及其制备方法和用途 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8518658D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Medicaments |
DE3901814A1 (de) | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
US5506192A (en) | 1990-06-07 | 1996-04-09 | Sandoz Ltd. | Substituted phthalides and heterocyclic phthalides |
US5412117A (en) | 1990-07-27 | 1995-05-02 | Chugai Seiyaku Kabushiki Kaisha | Benzopyran derivatives |
US5401848A (en) | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
US5817693A (en) | 1991-11-05 | 1998-10-06 | Cousins; Russell Donovan | Endothelin receptor antagonists |
DK0612244T3 (da) | 1991-11-05 | 2002-01-14 | Smithkline Beecham Corp | Endothelinreceptorantagonister |
US5288749A (en) * | 1991-12-20 | 1994-02-22 | Abbott Laboratories | Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
ZA93436B (en) | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
WO1994004521A1 (en) | 1992-08-17 | 1994-03-03 | Chugai Seiyaku Kabushiki Kaisha | Benzopyran and benzoxazine derivatives |
US5374643A (en) | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
AP573A (en) | 1993-04-27 | 1997-01-30 | Smithkline Beecham Corp | Endothelin receptor antagonists. |
US5739135A (en) | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
US6150402A (en) | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
JPH08217694A (ja) * | 1995-02-09 | 1996-08-27 | Pola Chem Ind Inc | 抗掻痒皮膚外用剤 |
US5869478A (en) | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
AU6252296A (en) | 1995-06-30 | 1997-02-05 | Pharmacia & Upjohn Company | 1,6-disubstituted isochromans for treatment of migraine headaches |
US5663194A (en) | 1995-07-25 | 1997-09-02 | Mewshaw; Richard E. | Chroman-2-ylmethylamino derivatives |
US5935958A (en) | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
EP1019035A4 (de) | 1996-08-21 | 2001-10-17 | Smithkline Beecham Corp | Il-8-rezeptorantagonisten |
JPH10195056A (ja) | 1996-11-12 | 1998-07-28 | Takeda Chem Ind Ltd | 縮合ベンゼン誘導体、その製造法および剤 |
AUPO390996A0 (en) * | 1996-11-29 | 1996-12-19 | Fujisawa Pharmaceutical Co., Ltd. | Urea derivatives |
US6559144B2 (en) | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
EP0971878B1 (de) | 1997-02-27 | 2008-03-26 | Takeda Pharmaceutical Company Limited | Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta |
TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
FR2778662B1 (fr) | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN1297550C (zh) | 1998-12-04 | 2007-01-31 | 武田药品工业株式会社 | 苯并呋喃衍生物及其制备和用途 |
ATE297905T1 (de) | 1999-09-30 | 2005-07-15 | Pfizer Prod Inc | 6-azauracilderivate als liganden der thyroidrezeptoren |
AU2001244700A1 (en) | 2000-04-03 | 2001-10-15 | Takeda Chemical Industries Ltd. | Process for producing amine derivatives |
WO2001085172A1 (en) | 2000-05-10 | 2001-11-15 | Smithkline Beecham Corporation | Novel anti-infectives |
KR20020097484A (ko) | 2000-05-19 | 2002-12-31 | 다케다 야쿠힌 고교 가부시키가이샤 | β-씨크리타아제 억제제 |
AU2001280187A1 (en) | 2000-08-28 | 2002-03-13 | Toray Industries, Inc. | Cyclic amine derivatives |
US6451808B1 (en) * | 2000-10-17 | 2002-09-17 | Depomed, Inc. | Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists |
AR035858A1 (es) | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
AR036081A1 (es) | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
US6982332B2 (en) * | 2001-06-07 | 2006-01-03 | Wayne State University | Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
CN1561338A (zh) | 2001-10-04 | 2005-01-05 | 惠氏公司 | 作为5-羟基色胺-6配体的苯并二氢吡喃衍生物 |
WO2003029239A1 (en) | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
AU2002359320A1 (en) | 2001-10-29 | 2003-05-12 | Smithkline Beecham Corporation | Novel anit-infectives |
WO2003059356A2 (en) | 2001-10-30 | 2003-07-24 | Smithkline Beecham Corporation | Novel anti-infectives |
WO2003099801A1 (en) | 2002-05-24 | 2003-12-04 | Smithkline Beecham Corporation | Novel anti-infectives |
US7943639B2 (en) | 2002-06-20 | 2011-05-17 | Proximagen Limited | Compounds |
US20040162285A1 (en) | 2002-11-01 | 2004-08-19 | Pratt John K. | Anti-infective agents |
US20040097492A1 (en) | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
US7902203B2 (en) | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
US20050075331A1 (en) | 2003-10-06 | 2005-04-07 | Pratt John K. | Anti-infective agents |
WO2004052312A2 (en) | 2002-12-11 | 2004-06-24 | Smithkline Beecham Corporation | Anti-infectives |
WO2004052313A2 (en) | 2002-12-11 | 2004-06-24 | Smithkline Beecham Corporation | Anti-infectives |
AU2003297235A1 (en) | 2002-12-17 | 2004-07-22 | Smithkline Beecham Corporation | Anti-infectives |
WO2005019191A2 (en) | 2003-08-25 | 2005-03-03 | Abbott Laboratories | 1, 1-dioxido-4h-1,2,4-benzothiadiazine derivate und verwandte verbindungen als inhibitoren der hcv polymerase zur behandlung von hepatitis c |
WO2005037223A2 (en) | 2003-10-15 | 2005-04-28 | Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
JP2007527412A (ja) | 2003-10-24 | 2007-09-27 | エグゼリクシス, インコーポレイテッド | Taoキナーゼモジュレーターおよび使用方法 |
BRPI0515860B8 (pt) * | 2004-12-21 | 2021-05-25 | Hoffmann La Roche | derivados de tetralin e indano, seus usos, e composição farmacêutica |
JP2009541252A (ja) * | 2006-06-20 | 2009-11-26 | エフ.ホフマン−ラ ロシュ アーゲー | テトラリン及びインダン誘導体ならびにそれらの使用 |
-
2005
- 2005-12-12 EP EP05825521A patent/EP1831152B1/de not_active Not-in-force
- 2005-12-12 PL PL05825521T patent/PL1831152T3/pl unknown
- 2005-12-12 CA CA002591800A patent/CA2591800A1/en not_active Abandoned
- 2005-12-12 AT AT05825521T patent/ATE409179T1/de active
- 2005-12-12 RU RU2007122406/04A patent/RU2388748C2/ru not_active IP Right Cessation
- 2005-12-12 WO PCT/EP2005/013293 patent/WO2006066748A1/en active IP Right Grant
- 2005-12-12 BR BRPI0519709-0A patent/BRPI0519709A2/pt not_active IP Right Cessation
- 2005-12-12 DE DE602005009977T patent/DE602005009977D1/de active Active
- 2005-12-12 KR KR1020077016595A patent/KR100889185B1/ko not_active IP Right Cessation
- 2005-12-12 AU AU2005318598A patent/AU2005318598B2/en not_active Ceased
- 2005-12-12 ES ES05825521T patent/ES2314749T3/es active Active
- 2005-12-12 JP JP2007547256A patent/JP2008524277A/ja not_active Ceased
- 2005-12-12 CN CNA2005800472162A patent/CN101111472A/zh active Pending
- 2005-12-12 MX MX2007007482A patent/MX2007007482A/es active IP Right Grant
- 2005-12-21 US US11/316,003 patent/US7576103B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101111472A (zh) | 2008-01-23 |
US20060154965A1 (en) | 2006-07-13 |
KR20070087171A (ko) | 2007-08-27 |
JP2008524277A (ja) | 2008-07-10 |
BRPI0519709A2 (pt) | 2009-03-10 |
EP1831152A1 (de) | 2007-09-12 |
EP1831152B1 (de) | 2008-09-24 |
KR100889185B1 (ko) | 2009-03-16 |
PL1831152T3 (pl) | 2009-03-31 |
AU2005318598A1 (en) | 2006-06-29 |
US7576103B2 (en) | 2009-08-18 |
RU2388748C2 (ru) | 2010-05-10 |
DE602005009977D1 (de) | 2008-11-06 |
ES2314749T3 (es) | 2009-03-16 |
RU2007122406A (ru) | 2009-01-27 |
MX2007007482A (es) | 2007-07-20 |
CA2591800A1 (en) | 2006-06-29 |
WO2006066748A1 (en) | 2006-06-29 |
AU2005318598B2 (en) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE409179T1 (de) | Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten | |
DE602006007556D1 (de) | Heteroarylsulfonylstilbene als 5-ht2a-antagonisten | |
BRPI0715579A2 (pt) | "composto, composição farmacêutica e uso de um composto" | |
ATE396183T1 (de) | Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors | |
TW200633964A (en) | Tetralin and indane derivatives and uses thereof | |
NO20071593L (no) | Pyrimidinderivater | |
MX2010003155A (es) | Derivados de ciclopropil aril amida y uso de los mismos. | |
ATE483707T1 (de) | 2-cyclopropylthiazolderivate | |
ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
WO2007147771A3 (en) | Tetralin and indane derivatives and uses thereof | |
SE0401971D0 (sv) | Piperidne derivatives | |
UA94065C2 (en) | Dihydropseudoerythromycin derivatives | |
DE602008004265D1 (de) | Trans-3-aza-bicyclo-ä3.1.0ü-hexan-derivate | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren | |
MX2010003156A (es) | Derivados de aril amida substituida con tetrazol y usos de los mismos. | |
ATE466842T1 (de) | 3-substituierte pyridinderivate als h3- antagonisten | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
NO20080033L (no) | Kinolinderivater som NK3-antagonister | |
EA200401455A1 (ru) | Производные бензоксазина в качестве модуляторов 5-htи их применение | |
TW200738697A (en) | Benzimidazole derivatives as 5-HT6,5-HT24 | |
PL1893589T3 (pl) | PODSTAWIONE POCHODNE N-BENZO[D]IZOKSAZOL-3-ILOAMINY JAKO INHIBITORY RECEPTORÓW mGluR5, SEROTONINY (5-HT) I NORADRENALINY I ICH ZASTOSOWANIE DO WYTWARZANIA ŚRODKÓW LECZNICZYCH | |
BRPI0406704A (pt) | Antagonistas de 5ht~7~ e agonistas inversos | |
ATE465151T1 (de) | 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren | |
ATE448216T1 (de) | Tetralin- und indanderivate und anwendungen davon | |
MX2009001572A (es) | Derivados de arilpiperazina y usos de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1831152 Country of ref document: EP |